e-ISSN: Pending

Browse the failure-mode index

21,266 real negative results, null findings, and replication failures. Search the index →

WASTE indexes published research — it does not host or republish full papers. Each entry is a metadata record compiled from open scholarly databases; the abstract is shown in full only where the paper is openly licensed, otherwise a short excerpt under fair use. Classifications are automated and approximate.

Negative / Null Result ReportMedicine

Drug profile: galcanezumab for prevention of cluster headache.

Mudugal D, Monteith TS · 2021 · Expert review of neurotherapeutics

Introduction : Cluster headache [CH] is a severely disabling trigeminal autonomic cephalalgia [TAC]. Approximately 1 in 1,000 adults are affected by CH. Calcitonin gene-related peptide [CGRP] is an important mediator in the pathophysiology…

View details →
Negative / Null Result ReportMedicine

Reexamination of the Embolic Stroke of Undetermined Source Concept.

Albers GW, Bernstein R, Brachmann J et al. · 2021 · Stroke

Occult atrial fibrillation (AF) is a leading cause of stroke of unclear cause. The optimal approach to secondary stroke prevention for these patients remains elusive. The term embolic stroke of undetermined source (ESUS) was coined to…

View details →
Failed Experiment ReportOpen accessMedicine

Survival, neurocognitive function, and health-related quality of life outcomes after rituximab-methotrexate, BCNU, teniposide, and prednisolone for primary CNS lymphoma: Final results of the HOVON 105/ALLG NHL 24 study.

Bromberg JEC, Issa S, van der Holt B et al. · 2024 · Neuro-oncology

Background Studies on the efficacy of rituximab in primary CNS lymphoma (PCNSL) reported conflicting results. Our international randomized phase 3 study showed that the addition of rituximab to high-dose methotrexate, BCNU, teniposide, and…

View details →
Negative / Null Result ReportOpen accessMedicine

SAFFRON-301: a randomised phase III study of sitravatinib in combination with tislelizumab in patients with locally advanced or metastatic non-small cell lung cancer.

Zhou Q, Gao B, Hu J et al. · 2026 · BMJ oncology

Background Many patients with non-small cell lung cancer (NSCLC) have tumours that are either refractory or develop resistance following an initial response to anti-programmed cell death protein (ligand)-1 (PD-(L)1)-based treatment,…

View details →
Negative / Null Result ReportOpen accessMedicine

Autoimmune Bullous Diseases: Therapeutic Update.

Kasperkiewicz M, van Beek N, Schmidt E · 2026 · Drugs

Autoimmune blistering diseases (AIBDs) are a heterogeneous group of at least a dozen disorders characterized by autoantibodies against structural proteins of desmosomes in the skin and surface-close epithelia in pemphigus and of the…

View details →
Failed Experiment ReportOpen accessMedicine

Interpreting clinical trial outcomes complicated by placebo response with an assessment of false-negative and true-negative clinical trials in depression using propensity-weighting.

Gomeni R, Hopkins S, Bressolle-Gomeni F et al. · 2023 · Translational psychiatry

The objective of this study was to evaluate the performances of the propensity score weighted (PSW) methodology in a post-hoc re-analysis of a failed and a negative RCTs in depressive disorders. The conventional study designs,…

View details →
Negative / Null Result ReportMedicine

RETRACTED: F173. Negative Trial of Scopolamine in Major Depressive Disorder Does Not Demonstrate Neurophysiological Changes Seen With the Antidepressant Response of Ketamine.

Park L, Furey M, Nugent A et al. · 2018 · Biological psychiatry

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This conference abstract has been retracted at the request of author Maura Furey,…

View details →
Negative / Null Result ReportOpen accessMedicine

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial.

Molto A, López-Medina C, Van den Bosch FE et al. · 2021 · Annals of the rheumatic diseases

Objectives To compare the benefits of a tight-control/treat-to-target strategy (TC/T2T) in axial spondyloarthritis (axSpA) with those of usual care (UC). Methods Pragmatic, prospective, cluster-randomised, controlled, open, 1-year trial…

View details →
Negative / Null Result ReportOpen accessMedicine

Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis.

Denton CP, Del Galdo F, Khanna D et al. · 2022 · Rheumatology (Oxford, England)

Objectives The cytokine oncostatin M (OSM) is implicated in the pathology of SSc. Inhibiting OSM signalling using GSK2330811 (an anti-OSM monoclonal antibody) in patients with SSc has the potential to slow or stop the disease process.…

View details →
Replication FailureOpen accessMedicine

Factors Associated With Loss of Fecal Biomarker Accuracy During Routine Assessment of Inflammatory Bowel Disease.

Kendall C, Swaminathan A, Borichevsky GM et al. · 2026 · JGH open : an open access journal of gastroenterology and hepatology

Background Fecal calprotectin (fCal) and fecal myeloperoxidase (fMPO) have been proposed as biomarkers for monitoring inflammatory bowel disease (IBD); however, their reliability is not fully established. This study investigated clinical…

View details →
Negative / Null Result ReportMedicine

Evaluating the reliability of the Word-Sentence Association Paradigm (WSAP) as an interpretation bias assessment across ethnoracial groups.

Ferguson I, George G, Wu C et al. · 2025 · Cognitive therapy and research

Background The tendency to negatively interpret ambiguous situations (i.e., interpretation bias) is associated with the development and maintenance of emotional disorders. Reliable measures of this transdiagnostic construct are critical…

View details →
Negative / Null Result ReportOpen accessMedicine

In clinical hand osteoarthritis research, self-reported pain questionnaires do not reflect the patient experience.

van der Meulen C, van de Stadt LA, Kroon FPB et al. · 2025 · Rheumatology (Oxford, England)

Objective Pain in hand osteoarthritis (OA) is evaluated with repeated pain questionnaires. It is unclear whether these questionnaires adequately capture changes in pain recalled by patients. This study investigated whether changes on pain…

View details →